Basel Medical Group Ltd BMGL Stock Analysis
- Nasdaq
- Stock
- Market closed · opens Monday 9:30 AM ET
$5.29 up $0.10, 1.93% at close Nov 6
Last close · Previous close $5.19
- Market cap
- At the Nov 6 close
- Dividend yield
- NoneLast 12 months
Price chart
$5.29up $0.10, 1.93%Fri, Nov 6 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$5.19Nov 5
- Volume1.68MNov 6 session
Shares traded on all US exchanges in the last completed session. Live intraday volume covers IEX only, so it is left out.
- Avg. volume1.36MLast 21 sessions
The average daily shares traded over the last 21 trading sessions, about one calendar month.
- 52-week range: $2.56 to $18.48; now $5.29
The lowest and highest trades over the past 52 weeks, adjusted for splits. The marker shows the latest price.
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Past performance, measured to the Nov 6 close. Total return includes reinvested dividends.Price change only, without dividends. Compared with the S&P 500, using SPY.
BMGL beat the S&P 500 in 1 of 4 periods.
| Period | BMGL and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BMGL: up 58.9% S&P 500: down 5.6% | BMGL beat the S&P 500 by 64.5 percentage points Beat |
| 3M | BMGL: down 7.1% S&P 500: down 4.1% | BMGL trailed the S&P 500 by 3.0 percentage points Trailed |
| YTD | BMGL: down 10.0% S&P 500: up 8.7% | BMGL trailed the S&P 500 by 18.7 percentage points Trailed |
| 1Y | BMGL: down 70.4% S&P 500: up 10.9% | BMGL trailed the S&P 500 by 81.3 percentage points Trailed |
$10,000 invested in BMGL a year ago (Nov 6, 2025) would be worth about $2,959 at the close on , with dividends reinvested. The same amount in the S&P 500 would be worth about $11,088.
BMGL beat the S&P 500 in 1 of 4 periods.
| Period | BMGL and S&P 500 | vs S&P 500 |
|---|---|---|
| Short term | ||
| 1M | BMGL: up 58.9% S&P 500: down 5.6% | BMGL beat the S&P 500 by 64.5 percentage points Beat |
| 3M | BMGL: down 7.1% S&P 500: down 4.3% | BMGL trailed the S&P 500 by 2.8 percentage points Trailed |
| YTD | BMGL: down 10.0% S&P 500: up 7.8% | BMGL trailed the S&P 500 by 17.8 percentage points Trailed |
| 1Y | BMGL: down 70.4% S&P 500: up 9.7% | BMGL trailed the S&P 500 by 80.1 percentage points Trailed |
$10,000 invested in BMGL a year ago (Nov 6, 2025) would be worth about $2,959 at the close on , not counting dividends. The same amount in the S&P 500 would be worth about $10,969.
All-time high
$72.96
Closing high on . Now 92.7% below that record.
Split-adjusted daily closes since Feb 25, 2025.
Stock splits
1
1-for-12 on . Share counts adjust after each split.
Valuation
Financials
Reported results, not forecasts. From company filings via Tiingo; the latest report is Q4 FY26, the quarter ended Jun 30, 2026, and balance-sheet figures are as of Jun 30, 2026. 12-month figures aren’t available until four quarters are reported.
Revenue and net income
12-month figures aren’t available until four quarters are reported.
Data table
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| Q4 FY23 (Jun 30, 2023) | Not reported | Not reported | Not reported |
| Q4 FY24 (Jun 30, 2024) | Not reported | Not reported | Not reported |
| Q2 FY25 (Dec 31, 2024) | Not reported | Not reported | Not reported |
| Q4 FY25 (Jun 30, 2025) | Not reported | Not reported | Not reported |
| Q2 FY26 (Dec 31, 2025) | Not reported | Not reported | Not reported |
| Q4 FY26 (Jun 30, 2026) | Not reported | Not reported | Not reported |
| Period | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| FY23 (Jun 30, 2023) | $9.70M | $1.78M | Paused See the note under the price. |
| FY24 (Jun 30, 2024) | $10.05M | $2.07M | Paused See the note under the price. |
| FY25 (Jun 30, 2025) | $11.32M | −$10.64M | Paused See the note under the price. |
| FY26 (Jun 30, 2026) | $12.81M | −$582.72K | −$0.61 |
Margins
- Gross
- Operating
- Net
The lines show each quarter. What margins tell you
Cash flow
12-month figures aren’t available until four quarters are reported.
Shareholder returns
12-month figures aren’t available until four quarters are reported.
Balance sheet
- $409.46KAs of Jun 30, 2026
Cash plus short- and long-term marketable securities on the Jun 30, 2026 balance sheet.
- Total debt$6.69MAs of Jun 30, 2026
- Net debt$6.28MAs of Jun 30, 2026
- 1.23As of Jun 30, 2026
Current assets divided by current liabilities on the Jun 30, 2026 balance sheet. Above 1 means short-term assets cover the bills due within a year.
Current ratio = Current assets ÷ Current liabilitiesCurrent ratio - 1.71As of Jun 30, 2026
Total debt divided by shareholders’ equity on the Jun 30, 2026 balance sheet: a measure of financial leverage.
D/E = Total debt ÷ Shareholders’ equityDebt-to-equity ratio
Financial strength
12-month figures aren’t available until four quarters are reported.
About Basel Medical Group Ltd
Basel Medical Group Ltd
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Singapore
- SEC filings
- EDGAR (opens in a new tab)
- Exchange
- Nasdaq
- Asset type
- Common stock
- Price history since
BMGL news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
BMGL stock FAQ
What is BMGL stock’s price today?
Basel Medical Group (BMGL) traded at $5.29 at the close on , up $0.10 (1.93%) from the previous close of $5.19. Over the past 52 weeks it has traded between $2.56 and $18.48.
Does BMGL pay a dividend?
Basel Medical Group hasn’t paid a dividend in the last twelve months.
What is BMGL’s 52-week high and low?
Over the past 52 weeks BMGL has traded as low as $2.56 and as high as $18.48. At $5.29 at the close on , it is 71.4% below that high and 106.6% above the low.
What is BMGL’s all-time high?
BMGL’s highest closing price was $72.96 on , adjusted for stock splits. At $5.29 at the close on , it is 92.7% below that record.
Has BMGL stock ever split?
Yes, once: 1-for-12 on .
How has BMGL stock performed?
Including dividends and measured to the close on , BMGL has returned −10.0% so far this year and −70.4% over the past year. Over the same periods the S&P 500, measured by SPY, returned +8.7% and +10.9%. Past performance doesn’t predict future returns.
What sector and industry is Basel Medical Group in?
Basel Medical Group is in the Healthcare sector and the Medical Care Facilities industry, and is headquartered in Singapore.
What exchange does BMGL trade on?
Basel Medical Group trades on the Nasdaq under the ticker symbol BMGL. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.